Lead Therapeutics raises $17M for China-based work in cancer and immunology
See our story about this San Mateo, Calif., drug-discovery company in Tuesday’s daily briefing at VentureBeat Life Sciences.
Next Story: Networked Insights offers new Internet market research
Previous Story: Navigenics raises more than $25M for personal genetics
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.